Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.360
+0.280 (6.86%)
At close: Feb 19, 2026, 4:00 PM EST
4.270
-0.090 (-2.06%)
After-hours: Feb 19, 2026, 7:44 PM EST
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $319.73 million as of February 19, 2026. Its market cap has increased by 3,004.22% in one year.
Market Cap
319.73M
Enterprise Value
305.85M
1-Year Change
3,004.22%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $319.73M, an increase of 464.90%. That is a compound annual growth rate of 18.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 299.20M | -15.53% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 279.12M |
| Avalo Therapeutics | 278.99M |
| Abeona Therapeutics | 273.12M |
| Sutro Biopharma | 272.61M |
| X4 Pharmaceuticals | 271.05M |
| Aardvark Therapeutics | 270.86M |
| Neurogene | 269.83M |
| Opus Genetics | 268.27M |